Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for post-POEM pain
NCT03702647Completed
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in achalasia (2 arms). Primary endpoint: Post-POEM pain level. Started Jun 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
achalasia
Beyond the preview
Go deeper on NCT03702647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702647.